| Product Code: ETC6740950 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, China continued to import cyclooxygenase 2 inhibitors primarily from the USA, India, Japan, Germany, and Belgium. Despite a negative Compound Annual Growth Rate (CAGR) of -7.29% from 2020 to 2024 and a further decline in the growth rate from 2023 to 2024 at -13.39%, the market remained relatively stable with low concentration, as indicated by the Herfindahl-Hirschman Index (HHI). This suggests a consistent flow of imports from diverse sources, maintaining a competitive market landscape for cyclooxygenase 2 inhibitors in China.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Cyclooxygenase 2 Inhibitor Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume, 2022 & 2032F |
3.3 China Cyclooxygenase 2 Inhibitor Market - Industry Life Cycle |
3.4 China Cyclooxygenase 2 Inhibitor Market - Porter's Five Forces |
3.5 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Types, 2022 & 2032F |
3.7 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Indication, 2022 & 2032F |
3.8 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By End-Users, 2022 & 2032F |
3.9 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 China Cyclooxygenase 2 Inhibitor Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in China leading to a higher demand for cyclooxygenase 2 inhibitors. |
4.2.2 Growing elderly population in China who are more prone to conditions requiring the use of cyclooxygenase 2 inhibitors. |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for pharmaceutical products in China may hinder the market growth. |
4.3.2 Competition from alternative treatments and therapies in the Chinese healthcare market can limit the adoption of cyclooxygenase 2 inhibitors. |
5 China Cyclooxygenase 2 Inhibitor Market Trends |
6 China Cyclooxygenase 2 Inhibitor Market, By Types |
6.1 China Cyclooxygenase 2 Inhibitor Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Drug Type, 2022 - 2032F |
6.1.3 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Celecoxib, 2022 - 2032F |
6.1.4 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Rofecoxib, 2022 - 2032F |
6.1.5 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Valdecoxib, 2022 - 2032F |
6.1.6 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Amlodipine, 2022 - 2032F |
6.1.7 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 China Cyclooxygenase 2 Inhibitor Market, By Types |
6.2.1 Overview and Analysis |
6.2.2 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Selective cox 2 inhibitor, 2022 - 2032F |
6.2.3 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Non-selective cox 2 inhibitor, 2022 - 2032F |
6.3 China Cyclooxygenase 2 Inhibitor Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Osteoarthritis, 2022 - 2032F |
6.3.3 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Rheumatoid arthritis, 2022 - 2032F |
6.3.4 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2022 - 2032F |
6.4 China Cyclooxygenase 2 Inhibitor Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Specialty Clinics, 2022 - 2032F |
6.4.4 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2022 - 2032F |
6.5 China Cyclooxygenase 2 Inhibitor Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Hospital Pharmacy, 2022 - 2032F |
6.5.3 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Retail Pharmacy, 2022 - 2032F |
6.5.4 China Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2022 - 2032F |
7 China Cyclooxygenase 2 Inhibitor Market Import-Export Trade Statistics |
7.1 China Cyclooxygenase 2 Inhibitor Market Export to Major Countries |
7.2 China Cyclooxygenase 2 Inhibitor Market Imports from Major Countries |
8 China Cyclooxygenase 2 Inhibitor Market Key Performance Indicators |
8.1 Average prescription rates of cyclooxygenase 2 inhibitors by healthcare providers in China. |
8.2 Number of clinical trials and research studies focusing on the efficacy and safety of cyclooxygenase 2 inhibitors in Chinese patients. |
8.3 Patient adherence rates to cyclooxygenase 2 inhibitor treatment regimens in China. |
9 China Cyclooxygenase 2 Inhibitor Market - Opportunity Assessment |
9.1 China Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 China Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Types, 2022 & 2032F |
9.3 China Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Indication, 2022 & 2032F |
9.4 China Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By End-Users, 2022 & 2032F |
9.5 China Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 China Cyclooxygenase 2 Inhibitor Market - Competitive Landscape |
10.1 China Cyclooxygenase 2 Inhibitor Market Revenue Share, By Companies, 2025 |
10.2 China Cyclooxygenase 2 Inhibitor Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here